Evidence (4857 claims)
Adoption
5586 claims
Productivity
4857 claims
Governance
4381 claims
Human-AI Collaboration
3417 claims
Labor Markets
2685 claims
Innovation
2581 claims
Org Design
2499 claims
Skills & Training
2031 claims
Inequality
1382 claims
Evidence Matrix
Claim counts by outcome category and direction of finding.
| Outcome | Positive | Negative | Mixed | Null | Total |
|---|---|---|---|---|---|
| Other | 417 | 113 | 67 | 480 | 1091 |
| Governance & Regulation | 419 | 202 | 124 | 64 | 823 |
| Research Productivity | 261 | 100 | 34 | 303 | 703 |
| Organizational Efficiency | 406 | 96 | 71 | 40 | 616 |
| Technology Adoption Rate | 323 | 128 | 74 | 38 | 568 |
| Firm Productivity | 307 | 38 | 70 | 12 | 432 |
| Output Quality | 260 | 71 | 27 | 29 | 387 |
| AI Safety & Ethics | 118 | 179 | 45 | 24 | 368 |
| Market Structure | 107 | 128 | 85 | 14 | 339 |
| Decision Quality | 177 | 75 | 37 | 19 | 312 |
| Fiscal & Macroeconomic | 89 | 58 | 33 | 22 | 209 |
| Employment Level | 74 | 34 | 78 | 9 | 197 |
| Skill Acquisition | 98 | 36 | 40 | 9 | 183 |
| Innovation Output | 121 | 12 | 24 | 13 | 171 |
| Firm Revenue | 98 | 35 | 24 | — | 157 |
| Consumer Welfare | 73 | 31 | 37 | 7 | 148 |
| Task Allocation | 87 | 16 | 34 | 7 | 144 |
| Inequality Measures | 25 | 76 | 32 | 5 | 138 |
| Regulatory Compliance | 54 | 61 | 13 | 3 | 131 |
| Task Completion Time | 89 | 7 | 4 | 3 | 103 |
| Error Rate | 44 | 51 | 6 | — | 101 |
| Training Effectiveness | 58 | 12 | 12 | 16 | 99 |
| Worker Satisfaction | 47 | 33 | 11 | 7 | 98 |
| Wages & Compensation | 54 | 15 | 20 | 5 | 94 |
| Team Performance | 47 | 12 | 15 | 7 | 82 |
| Automation Exposure | 27 | 26 | 10 | 6 | 72 |
| Job Displacement | 6 | 39 | 13 | — | 58 |
| Hiring & Recruitment | 40 | 4 | 6 | 3 | 53 |
| Developer Productivity | 34 | 4 | 3 | 1 | 42 |
| Social Protection | 22 | 11 | 6 | 2 | 41 |
| Creative Output | 16 | 7 | 5 | 1 | 29 |
| Labor Share of Income | 12 | 6 | 9 | — | 27 |
| Skill Obsolescence | 3 | 20 | 2 | — | 25 |
| Worker Turnover | 10 | 12 | — | 3 | 25 |
Productivity
Remove filter
Real clinical value depends critically on how AI tools interact with radiologists in practice (integration design and human-AI interaction).
Conceptual models and synthesis of reader studies, simulation/interaction studies, usability and qualitative deployment evaluations that compare standalone algorithm performance versus clinician+AI workflows.
Practical takeaway: effectiveness of human–AI teaming in security tasks depends heavily on human ability to formulate context-rich prompts; autonomous workflows that self-manage prompting and tool selection can be more effective.
Synthesis of empirical observations from the live CTF (41 participants) and the autonomous agent benchmark (4 agents), showing human prompting failures limiting team performance and autonomous agents with self-directed prompting achieving higher performance.
Participants’ perceptions, trust, and expectations about the AI shifted after hands-on use (qualitative observation).
Pre- vs. post-AI qualitative measures and observational analysis collected during the live CTF (self-reports/observations of trust and expectations after using the instrumented AI).
Implication for substitution: Because there was no main effect of partner type on collaboration proficiency, AI teammates may substitute for humans on short, temporary tasks without clear productivity loss—conditional on emotional and empathetic factors.
Inference by authors based on the null main effect of partner type combined with the observed role of emotion and service empathy in moderating/mediating collaboration proficiency (experimental evidence, n = 861).
Trust calibration influences project performance outcomes: organizations tend toward metric-driven evaluation of AI outputs and use AI to strategically augment human expertise, but miscalibration risks overreliance or inappropriate metric focus that can harm performance.
Based on participants' reported experiences in the 40 interviews and interpretive thematic analysis linking trust practices to observed/perceived performance consequences (shift to metric-based evaluation, strategic use, and noted risks).
Trust calibration shapes collaboration patterns, including delegation of oversight to systems or specialists, changes in communication networks (who talks to whom), and erosion of informal ad hoc communications used previously for tacit coordination.
Observed in interview narratives (40 interviews) and thematic coding showing repeated reports of shifted oversight roles, altered communication pathways, and reduced informal coordination after AI integration.
Trust calibration is produced and maintained through ongoing boundary work between humans and machines (i.e., teams continuously negotiate which inputs/responsibilities are treated as human versus machine).
Derived from participants' accounts in the 40 interviews and thematic analysis documenting repeated examples of role negotiation and boundary-setting between people and AI systems during project routines.
Trust in AI within project-based work is situational and socially distributed across team members, rather than a stable individual attitude.
The claim is based on thematic qualitative analysis of 40 semi-structured interviews with project professionals across multiple industries in the UK. Interview data showed variation in how different team members described their trust in systems depending on role, task, and context.
Explicit governance reduces negative externalities (bias, privacy breaches, loss of trust) but entails compliance costs that should be factored into adoption and diffusion models.
Conceptual claim synthesizing trade‑off arguments from governance and risk literatures and practitioner examples; not measured empirically in the paper.
Embedding AI into workflows may change firm boundaries (e.g., outsourcing models vs. in‑house systems) and make investments in internal auditability and explainability strategic assets.
Theoretical implication drawn from synthesis of organizational boundary theory and practitioner trends; suggested rather than empirically demonstrated within the paper.
AI is likely to continue shifting the frontier of early discovery and increase the throughput and quality of hypotheses, but persistent biological uncertainty and the cost of clinical validation mean AI will complement—not fully replace—traditional R&D for the foreseeable future.
Synthesis of technological trends, application successes and limitations, translational risk, and economic reasoning presented throughout the paper.
Proprietary data, precompetitive consortia, and platform consolidation can create barriers to entry; public-data initiatives could alter competitive dynamics.
Market-structure analysis and discussion of data-access models in the paper, with examples of consortia and proprietary platform effects.
Expect strong returns-to-scale and winner-take-most dynamics: large incumbents and well-funded startups with proprietary data/compute may dominate the field.
Economic reasoning and observations in the paper about data/compute concentration, platform effects, and market outcomes.
Realizing economic gains at scale from AI in drug R&D is constrained by data quality and access, high implementation and integration costs, regulatory uncertainty, and ethical/legal concerns; these constraints will shape how gains are distributed across firms, countries, and patients.
Aggregate conclusion of the narrative review synthesizing documented benefits and recurring constraints from published studies, case reports, industry/regulatory analyses; qualitative synthesis without quantitative projection of distributional outcomes.
Adoption of AI in pharma will increase demand for computational biologists, ML engineers, and data scientists and may displace or redefine some traditional bench roles.
Labor-market trend reports and organizational case studies included in the review noting hiring patterns and role changes; qualitative synthesis rather than comprehensive labor-market study.
AI could lower discovery costs and permit more entrants in niche/specialty therapy discovery, but clinical development costs remain a major barrier to entry.
Synthesis of reported reductions in early-stage discovery costs and persistent high clinical trial costs from studies and industry reports; heterogeneous evidence across therapeutic areas.
Upfront capital and proprietary data requirements may advantage large incumbents or well-funded startups and could increase market concentration unless data-sharing or open platforms emerge.
Market-structure analysis and industry examples in the narrative review; inference based on observed data-asset advantages and investment needs across firms.
AI shifts the cost structure of drug R&D toward higher fixed costs (data infrastructure, compute, ML talent) and potentially lower marginal costs for candidate generation and some preclinical activities.
Economic synthesis and industry reports in the review describing capital-intensive investments and reduced per-unit costs in algorithmic candidate generation; largely conceptual and based on case examples.
Early-stage unit costs and time-per-hit can fall with AI, but late-stage clinical trial costs driven by biology remain the primary bottleneck to overall R&D productivity gains.
Qualitative assessment of stage-specific effects based on industry observations and conceptual decomposition of R&D stages; no new cost accounting or econometric estimates provided.
AI can improve specific stages of drug discovery but cannot eliminate fundamental biological uncertainty.
Conceptual and thematic analysis across technological capability and R&D integration levels; supported by illustrative examples showing limits of prediction in complex biology.
Two opposing market forces will act: (a) democratization lowering entry barriers for startups, and (b) concentration where firms with premium proprietary data and integrated AI capture outsized returns.
Conceptual economic analysis and illustrative industry observations; no empirical market-structure measurement presented.
AI (including machine learning, generative AI, and NLP) is reshaping biomedical research and pharmaceutical R&D by creating distinct adoption archetypes within large pharmaceutical companies.
Editorial / conceptual synthesis using qualitative analysis and archetype classification based on cross-industry observations and illustrative examples; no systematic measurement or sample size reported.
Cross-DAO cooperation could reduce duplication and accelerate global public-good R&D (e.g., neglected diseases) but raises jurisdictional, regulatory arbitrage, and equity concerns.
Theoretical discussion and scenario analysis; no cross-DAO empirical case with measured outcomes is provided.
Techniques to mitigate data scarcity—transfer learning, data augmentation, physics-informed priors, active learning, and leveraging multimodal data—provide partial improvements but do not fully resolve generalization limits.
Review of methodological papers and empirical studies applying these techniques; synthesis indicates improvements in certain contexts but ongoing limitations documented across sources.
AI adoption shifts inventor composition within firms.
Analyses of inventor-level or inventor-aggregate characteristics before and after AI adoption showing changes in composition, using the staggered diff-in-diff approach.
Overall, AI adoption facilitates both refinement of existing knowledge (exploitation) and exploration of new technological domains (exploration).
Combined evidence: increases in exploitative-patent share (exploitation) together with increases in originality, generality and technological distance (exploration) using the stacked diff-in-diff approach.
Many of the fundamental advantages and challenges studied in distributed computing also arise in LLM teams.
Empirical and/or conceptual analysis reported by the authors mapping distributed computing phenomena to LLM-team behavior (the excerpt states this finding but does not include the experimental details or metrics).
Model transparency received 90% approval but still requires further refinement.
Stakeholder validation reporting a 90% approval rate for model transparency, while the authors note transparency needs additional work. (Summary does not specify transparency criteria or evaluation method.)
Ethical governance received 85% approval but requires further refinement.
Stakeholder validation results showing 85% approval for ethical governance aspects, with the paper noting the need for further refinement. (No details given on stakeholder composition or ethical framework used.)
These findings suggest that agent skills are a narrow intervention whose utility depends strongly on domain fit, abstraction level, and contextual compatibility.
Interpretation derived from the empirical pattern: majority of skills show no improvement, a few specialized skills help, and some harm — leading to the conclusion that utility depends on fit and context.
There is a fundamental tension between designing AI for complementarity (performance-boosting) and designing AI for alignment (trust-building) when training a single AI model to assist human decision making.
Conceptual and theoretical analysis presented in the paper identifying the trade-off; no dataset/sample-size given in the excerpt.
The transformative potential of AI is not automatic but is contingent upon the presence of digital literacy, contextualized tools, and a supportive ecosystem.
Interpretation and synthesis of empirical findings showing conditional effects and mediators from the questionnaire data; presented as a substantive conclusion in the paper.
Organizations must reconceptualize AI implementation as a fundamental redesign of work systems requiring new competencies, governance structures, and attention to human cognitive limits.
Normative recommendation based on the paper's synthesis of organizational adaptation literature and reported negative outcomes of current AI deployments; no empirical test of this prescriptive claim provided in the excerpt.
Factors identified as relevant to AI emergence/adoption include Technology Adoption Rate (AI1), Government Policies and Regulations (AI2), Labor Market Dynamics (AI3), Technological Advancements (AI4), Corporate Strategies (AI5), and Socio-cultural Factors (AI6).
Author-provided list of factors in the paper; no empirical quantification, weighting, or methodology for selecting these factors is given in the excerpt.
Facilitated access to AI reconfigures startup roles, organizational structures, and decision routines.
Analytic findings from semi-structured interviews pointing to changes in role definitions, reporting lines, and decision-making routines after AI adoption (qualitative evidence; sample size not specified).
AI adoption generates different effects across different occupations.
Summary statement based on analysis of publicly available labor market data (occupational-level heterogeneity asserted but specific datasets, sample sizes, and methods not described).
AI is not an unprecedented disruption; its effects can be situated within established economic frameworks related to automation and task substitution.
Conceptual analysis comparing recent AI developments to historical automation and task-substitution frameworks; empirical grounding claimed via publicly available labor market and productivity data (details not provided).
AI has emerged as a transformative force that influences economic systems, institutional functions, and daily human behaviors.
Stated as an overarching observation in the paper (theoretical/interpretive claim); no empirical methods or sample sizes are reported in the abstract.
Three developer archetypes are present: Enthusiasts, Pragmatists, and Cautious.
Classification/typology derived from the study's survey data of 147 developers (e.g., cluster analysis or thematic grouping) identifying three distinct groups based on usage patterns, attitudes, and intent.
Improvements in caseworker accuracy level off as chatbot accuracy increases (an "AI underreliance plateau").
Observed pattern in experimental results: incremental gains in caseworker accuracy diminish at higher chatbot accuracies, described by authors as an 'AI underreliance plateau' (specific curves or thresholds not in the excerpt).
The rapid global proliferation of Artificial Intelligence (AI) has created a profound paradox: while promising unprecedented productivity gains, its current trajectory exacerbates labor market polarization, deepens inequality, and threatens to fracture the 20th-century social contract.
Asserted in abstract; no empirical methods, datasets, or sample sizes described in the abstract (presumably supported in paper by literature review/argumentation).
AI’s labor market impacts in the Philippines are not technologically predetermined; outcomes will depend on policy choices related to skills development, governance, social protection, and innovation.
Integrated conceptual framework in the paper linking AI capabilities, occupational structure, and institutional mediation, supported by the scenario analysis which shows divergent outcomes conditional on policy settings.
Observed AI adoption patterns in the Philippines to date are cautious, with limited job loss but growing task reconfiguration and emerging skills gaps.
Firm- and worker-level evidence on AI adoption (surveys/interviews and/or administrative firm adoption data described in the paper) documenting current adoption practices, reported job impacts, task changes, and reported skill shortages.
A significant share of Philippine employment is exposed to generative AI—particularly in service-sector and BPO-related occupations.
Occupational exposure analysis using Philippine labor force data (occupational employment shares and task-content measures) combined with task-level evidence on generative AI capabilities.
AI alters job structures, workflow patterns, and human roles in decision-making processes.
Thematic content analysis of recent accredited journal literature as part of the qualitative library research (sources not enumerated).
AI is fundamentally transforming the workplace by creating new opportunities, intensifying challenges, and redefining professional skills.
Qualitative library research: systematic documentation and thematic content analysis of recent accredited journal sources (number of sources not specified).
Contextual and technological factors (work environment and digital/AI intensity) enhance human-centered capabilities but do not substitute for them.
Authors state these factors were included as contextual moderators in the analysis and that results indicate they enhance but do not replace emotional/psychological predictors. The excerpt does not include moderator effect sizes, sample size, or statistical tests.
AI shows potential as an adjunct tool in acute GIB management but requires further validation to confirm its clinical utility.
Conclusion synthesizing review findings: high diagnostic metrics and workflow benefits but insufficient evidence on patient outcomes and safety.
AI enhances diagnostic accuracy and workflow efficiency but lacks robust evidence linking it to improved patient outcomes in acute GIB.
Synthesis in the discussion combining reported high diagnostic metrics and time savings with the paucity of studies reporting patient outcomes.
NQPF has stronger positive effects on supply chain efficiency in non-high-tech industries; high-tech sectors face integration challenges that weaken the effect.
Industry-level heterogeneity analysis on the 2012–2022 panel of Shanghai and Shenzhen A-share firms, comparing high-tech vs. non-high-tech industry subsamples.